Samsung Life Insurance (A032830) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
24 Jun, 2026Executive summary
Net profit for H1 2025 reached KRW 1.394 trillion, up 1.9% year-on-year, driven by strong health product sales, increased CSM amortization, and robust insurance service results.
Health new business CSM grew 27.6% year-on-year to KRW 1.1 trillion, expanding market dominance in health insurance.
Exclusive and GA channels contributed significantly to new business growth, with exclusive FC agents increasing by over 3,500 year-to-date.
The group maintains a leading market position in life insurance, asset management, and credit card services, with a diversified portfolio and strong capital base.
The company and its subsidiaries received unqualified audit opinions and maintain robust internal controls.
Financial highlights
Net profit for Q2 was KRW 759 billion, up from KRW 635 billion in Q1.
Insurance profit reached KRW 831 billion, up 16.8% year-on-year; investment profit was KRW 1.021 trillion, slightly lower year-on-year due to reduced subsidiary contributions.
Total assets stood at KRW 319.1 trillion as of June 2025, with shareholders' equity at KRW 34 trillion.
CSM balance at end-June was KRW 13.7 trillion, up KRW 0.8 trillion year-to-date.
Dividend payout for the prior fiscal year was KRW 808.1 billion, with a payout ratio of 38.4%.
Outlook and guidance
Targeting end-of-year KICS ratio above 180%, maintaining capital adequacy and supporting dividend policy.
Plans to gradually increase shareholder return to a mid-term target of 50%, with payout ratio expected to exceed 40% in line with regulatory changes.
Focus on sustaining health CSM share at around 85% and growing aggregate new business CSM.
Ongoing focus on digital transformation, product innovation, and global expansion, especially in asset management and insurance.
Focus on expanding environmentally friendly investments and strengthening ESG management.
Latest events from Samsung Life Insurance
- Net profit up 40.5% to KRW 1.37T in H1 2024; health CSM leads; 50% payout ratio targeted.A032830
Q2 20248 Jul 2026 - Q1 2025 net profit reached KRW 677.5B, assets KRW 318.9T, solvency margin 218.8%.A032830
Q1 20258 Jul 2026 - Q3 net profit up 41.6% YoY, strong health insurance and capital, CSM at ₩13 trillion.A032830
Q3 202424 Jun 2026 - Net profit up 3.7% YoY, with strong capital, health CSM growth, and higher equity.A032830
Q3 202524 Jun 2026 - Q1 net income up 89.5%–90% YoY, CSM and health product sales surged, K-ICS ratio at 210%.A032830
Q1 202621 May 2026 - FY2025 net profit rose 9.3% to KRW 2.3T, with record CSM and DPS up 18%; strong 2026 growth targeted.A032830
Q4 202512 Apr 2026 - Record profit, robust capital, and higher dividends driven by health segment growth.A032830
Q4 20248 Jan 2026